Search Results: frontotemporal
Kayleigh Watts, from Addenbrooke’s Hospital in Cambridge has worked with people with frontotemporal dementia (FTD) and their loved ones during the Covid-19 pandemic. She reflects on the impact of COVID-19 on those with FTD, in a piece originally written for the Psychologist Magazine.
Dr Tammaryn Lashley’s team at University College London are expanding their work to find out if different forms of frontotemporal dementia can have different effects on astrocytes, a key cell type in the brain.
Researchers at Imperial College London are investigating how fragments of TDP-43 can trigger the creation of toxic protein clumps in the brain.
Researchers at University College London are studying how different chemical tags on DNA switch genes on or off in FTD.
Researchers at King’s College London are investigating new mechanisms of nerve cell death and the role this might play in frontotemporal dementia
Dementia is thought to affect around 850,000 people in the UK. Most people associate the condition with Alzheimer’s disease, the most common cause of dementia. But there are other diseases that can cause the symptoms of dementia – including frontotemporal dementia (FTD).
How proteins go wrong in frontotemporal dementia remains a key aim for dementia researchers.
University of Sheffield researcher will seek to extend our knowledge of how DNA instability is involved in frontotemporal dementia caused by the C9orf72 mutation.
Researchers at the University of Sheffield are investigating why the communication between nerve cells is lost in frontotemporal dementia.
Researchers in the US have found that a protein called Lysine specific histone demethylase (LSD1) could protect against neurodegeneration in mice, and suggest that its function could be compromised in Alzheimer’s disease and frontotemporal dementia (FTD). The results of the study are published today in Nature Communications. LSD1 is a protein known to be critical…